Posts by John

New research reveals that Calocurb effectively triggers GLP-1 for fat loss while protecting lean muscle mass. Learn how this supplement aids metabolic health.

The FDA has approved a new targeted therapy for non-small cell lung cancer (NSCLC), marking a major expansion in precision oncology for GSK.

A breakthrough Alzheimer’s drug targeting a complex protein has shown success in slowing cognitive decline, offering new hope for neurodegenerative care.

FDA advisors recently signaled support for compounded peptides. Learn how this regulatory shift impacts clinical access and pharmacy standards.

European regulators are mandating stricter clinical trial transparency to reduce bias and improve patient safety in global medical research. Read more.

A groundbreaking breast cancer trial at UAB shows promising results for a HER2+ patient, offering a potential new path for aggressive cancer treatment.

Johnson & Johnson receives FDA clearance for the OTTAVA surgical system. Discover how this innovative, space-saving robotic platform will transform surgery.

Researchers use AI to discover new drug targets for psoriasis, offering hope for more effective treatments for patients with treatment-resistant skin disease.

Dexcom joins a new FDA-CMS pilot program aimed at streamlining the path for medical devices, potentially accelerating patient access to critical technology.

New research in Nature highlights a breakthrough armored GPC3 CAR-T therapy, showing potential to treat advanced liver cancer by overcoming tumor defenses.